ARCH Venture Fund X L.P. 13D/13G Filings for Verve Therapeutics, Inc. (VERV)

ARCH Venture Fund X L.P. 13D and 13G filings for Verve Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-13
4:08 pm
Sale		 2022-12-31 13G Verve Therapeutics, Inc.
VERV		 ARCH Venture Fund X L.P. 0
0.000%		 -2,508,809decrease
(Position Closed)		 Filing
2022-02-09
1:26 pm
Purchase		 2021-12-31 13G Verve Therapeutics, Inc.
VERV		 ARCH Venture Fund X L.P. 2,508,809
5.200%		 2,508,809increase
(New Position)		 Filing